Not even close to being accurate Why anyone would believe anything you post is beyond me.
Federal domestic vaccine efforts have been funded by appropriations in COVID-19 relief acts, especially funding to U.S. Public Health Service (PHS) agencies and accounts. The following provides an overview of appropriations for selected domestic COVID-19 vaccine related activities. (With the exception of the mandatory funding provided by the American Rescue Plan Act of 2021 (ARPA), all funding amounts discussed below are classified as discretionary.) The following is meant to inform a general understanding of available funding, but may not capture every federal account that can be used for vaccine-related activities. In general, many of the HHS appropriations are available for multiple years or until expended, and some of the funding is transferrable between accounts by the HHS Secretary. This product does not address financing for vaccine administration, global vaccination funding, or related allocations and spending.
ARPA (P.L. 117-2) further provides appropriations that can be used for activities under this heading (all
ARPA funds are mandatory appropriations):
Section 2303 provides $6.05 billion to HHS, available until expended, for research,
development, manufacturing, production, and the purchase of vaccines, therapeutics, and
ancillary medical products and supplies—available for COVID-19 (or SARS-CoV-2), its
variants, and any disease with potential for creating a pandemic.
Section 2304 provides $500 million to FDA, available until expended, for a broad set of
activities, including for its review of the performance, safety, and effectiveness of
vaccines; inspection of vaccine manufacturing facilities; and oversight of the vaccine
Section 3101 provides $10 billion, available until September 30, 2025, for activities
under the Defense Production Act with respect to medical supplies and equipment for the
pandemic, including for vaccines and related supplies. Funds can support the purchase,
production, and distribution of such supplies. After September 30, 2022, funds can be
used to meet critical public health needs with respect to any pathogen that the President
has determined has the potential for creating a public health emergency.